Phase I trial of enadenotucirev in combination with nivolumab in patients with solid tumours
Latest Information Update: 04 Jul 2016
At a glance
- Drugs Enadenotucirev (Primary) ; Nivolumab (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Therapeutic Use
- Sponsors Akamis Bio
- 04 Jul 2016 New trial record
- 30 Jun 2016 According to a media release, PsiOxus will be responsible for conducting the Phase 1 study with patient recruitment expected to start in the third quarter of 2016.